Melissa Officinalis Extract Calms Anxious Dogs: 2025 Study

Melissa Officinalis Extract Alters Dog Behavior and Metabolism: A 2025 Study

Twenty healthy beagles given a lemon balm extract for four weeks showed a significant behavioral shift. Their average behavioral score rose to 2.0, compared to -3.4 for dogs on a placebo. This 2025 study from researchers at Oniris and Nor-Feed SAS provides a molecular look at how botanical supplements may calm anxious dogs.

For dog owners, calming treats are a popular intervention for noise phobias, separation anxiety, and general stress. Evidence supporting their ingredients has often been anecdotal. New research published in BMC Veterinary Research moves the field from observation to mechanism. Using metabolomics, the team identified specific biochemical pathways altered by Melissa officinalis (lemon balm) in dogs.

The Science of Stress and the Role of GABA

Anxiety in dogs is more than undesirable behavior; it is a physiological state involving the nervous and endocrine systems. A core mediator is the neurotransmitter gamma-aminobutyric acid (GABA). GABA acts as the brain’s primary inhibitory signal, calming neuronal activity. Many pharmaceutical anxiolytics, like benzodiazepines, work by enhancing GABA’s effects.

This study measured a GABA-related metabolite called 4-hydroxybutyric acid (GHB). Levels of GHB decreased in all treatment groups compared to the placebo, suggesting the interventions influenced the GABAergic system. This biochemical change correlated with observable improvements in behavior, providing a two-part validation of effect.

How the Study Was Conducted

Lead authors A.S. Roy and F.Z. Aberkane designed a randomized, placebo-controlled trial. The twenty beagles were divided into four groups of five. Each group received a daily dietary supplement for 28 days:

• Placebo: Maltodextrose (200 mg/kg).
• MOE Group: A commercial hydro-alcoholic Melissa officinalis extract (200 mg/kg).
• RA Group: Rosmarinic acid (10.6 mg/kg), the identified major compound in the lemon balm extract.
• AC Group: α-casozepine (225 mg total), a milk protein-derived calming agent used as a reference.

After the treatment period, a standardized behavior evaluation developed by Oniris’ NP3 Unit was administered. Researchers also collected plasma for metabolomic analysis, a technique that profiles hundreds of small-molecule metabolites to reveal systemic biological changes.

Lemon Balm Extract Improved Behavioral Scores by 5.4 Points

The primary behavioral finding was clear. The placebo group had a mean score of -3.4. Scores for the supplemented groups were positive: 2.0 for the full lemon balm extract (MOE), 1.4 for rosmarinic acid alone (RA), and 0.8 for α-casozepine (AC). The 5.4-point difference between the placebo and MOE groups is statistically and practically significant. Our detailed analysis of these behavioral results is available in the article Lemon Balm Extract Improves Dog Behavior by 5.4 Points.

These scores assess a range of behaviors including posture, reaction to stimuli, and overall alertness. A higher score indicates a calmer, more relaxed state. The finding that the full plant extract performed best suggests potential synergy between rosmarinic acid and other compounds in lemon balm.

Metabolomics Reveals Specific Pathways

Beyond behavior, the untargeted metabolomics data offered a novel look at the internal effects. Each supplement produced a distinct metabolic signature:

• MOE (Full Extract): Impacted pathways related to lipid and bile acid metabolism.
• RA (Rosmarinic Acid): Altered fatty acid and lipid metabolism pathways.
• AC (α-casozepine): Affected lysine and sphingolipid metabolism.

The shift in lipid and bile acid metabolism with MOE is notable. Bile acids are now recognized as important signaling molecules that can influence brain function and stress responses through the gut-brain axis. This finding moves the discussion beyond simple neurotransmitter modulation and towards a more holistic systems view of anxiety. For a deeper look at the brain metabolite changes associated with botanical calming agents, see our companion piece, Lemon Balm Extract Calms Dogs, Modifies Brain Metabolites.

Practical Considerations for Choosing Calming Treats

This research empowers owners to make informed choices. When evaluating a calming treat, look for products that specify the active ingredient and its dosage.

Identifying Key Ingredients

Based on this study, lemon balm extract and its component rosmarinic acid show measurable effects. α-casozepine, a hydrolyzed milk protein, is another evidence-backed option. Other common ingredients like L-theanine or tryptophan have varying levels of research support. The study’s dose of 200 mg/kg of MOE provides a benchmark, though commercial treats will use lower, maintenance-level doses. Owners dealing with complex cases like separation anxiety should note that supplements are typically part of a broader management plan.

Limitations and Real-World Application

The study has important constraints. It used healthy beagles in a controlled environment, not dogs with diagnosed anxiety disorders in a home setting. The treatment duration was four weeks; long-term effects are unknown. Individual responses will vary based on breed, size, and the root cause of anxiety. A treat that modifies lipid metabolism may also interact with other health conditions, making veterinary consultation essential.

Supplements should complement, not replace, behavioral training and environmental management. For senior dogs showing signs of anxiety linked to cognitive decline, a different approach may be needed, as outlined in our Canine Cognitive Dysfunction Guide for Senior Dogs.

The Future of Evidence-Based Calming Supplements

This study demonstrates the value of metabolomics in veterinary nutraceutical research. Instead of simply noting that a dog seems calmer, scientists can now identify the specific biochemical shifts associated with that state. This allows for more precise formulation and quality control of products.

Future research will likely focus on the gut-brain axis mechanisms suggested by the bile acid findings and examine combinations of calming ingredients. Studies in client-owned dogs with specific anxiety diagnoses are the next necessary step to confirm these findings in real-world conditions.

Key Takeaways

• A 2025 controlled study found a lemon balm extract (Melissa officinalis) significantly improved calm behavior scores in dogs compared to a placebo.
• The active compound rosmarinic acid and the milk protein α-casozepine also showed positive effects, though the full extract was most effective.
• Metabolomic analysis revealed the supplements work in part by influencing the GABA system and altering specific metabolic pathways, including those for lipids and bile acids.
• This provides a scientific mechanism for how some calming treats may function, moving beyond anecdotal reports.
• Calming treats are a supportive tool, not a sole solution. They work best alongside behavioral training and environmental modifications.
• Always discuss the use of any new supplement with your veterinarian, especially if your dog has other health conditions.

This article is for informational purposes only. Consult a qualified professional for personalised advice.

Sources:
https://pubmed.ncbi.nlm.nih.gov/40646521/
https://pubmed.ncbi.nlm.nih.gov/33996972/